Dr. Zaineb Hamzaoui, Université Tunis el Mana, Tunisia
Dr. Zaineb Hamzaoui is a highly accomplished microbiologist with a Ph.D. from the Faculty of Sciences, Bizerte. 🎓 Her research focuses on antimicrobial resistance mechanisms, particularly in Klebsiella pneumoniae. With extensive experience in molecular biology and genomic sequencing, she currently holds a postdoctoral position at the Faculty of Medicine, Tunis. 🧬 Additionally, she contributes to academia as a part-time lecturer at the Maghreb Institute of Economic Sciences and Technology. Previously, she excelled as a Product Specialist at the African Biotechnology Society, showcasing her expertise in product development and customer engagement. 🌟
Publication Profile
Scopus
Orcid
Education
Dr. Zaineb Hamzaoui holds a Ph.D. in Biological Sciences, specializing in Microbiology, awarded in 2018 from the Faculty of Sciences, Bizerte. Her doctoral research focused on identifying carbapenem resistance mechanisms in Klebsiella pneumoniae strains isolated from the Charles Nicolle Hospital in Tunis. Prior to her Ph.D., she completed a Master’s degree in Microbiology in 2011 and a Bachelor’s degree in Life Sciences in 2008, both from Tunisian universities. Zaineb began her academic journey with a Diploma in the First Cycle of Life Sciences in 2006, following her high school graduation with a focus on Mathematics in 2004.
Professional Experience
Dr. Hamzaoui has been engaged in a Postdoctoral Contract at the Faculty of Medicine, Tunis, focusing on antimicrobial resistance research. Her responsibilities include next-generation genome sequencing of SARS-CoV-2, phenotypic and molecular studies on multi-drug resistant bacteria, and managing laboratory activities. She also serves as a part-time lecturer at the Maghreb Institute of Economic Sciences and Technology, where she prepares and delivers courses. Previously, from May 2022 to March 2023, she worked as a Product Specialist at the African Biotechnology Society, specializing in product training, marketing, and customer engagement strategies. 🧬📚
Research Focus
Dr. Zaineb Hamzaoui’s research primarily focuses on antimicrobial resistance in various pathogens, with a particular emphasis on Gram-negative bacteria. 🦠 Her contributions span extensive studies on the molecular mechanisms underlying resistance, including the characterization of carbapenemases and plasmid-mediated resistance genes. She has investigated the prevalence of multidrug-resistant strains in healthcare settings, highlighting the urgent need for effective infection control measures. Additionally, her work extends to understanding the dynamics of antimicrobial resistance in community settings, shedding light on the dissemination of resistant bacteria among vulnerable populations. Overall, Dr. Hamzaoui’s research endeavors aim to inform strategies for combating the growing threat of antimicrobial resistance. 🌐
Publication Top Notes
- Extensively drug-resistant Acinetobacter baumannii co-producing VIM-2 and OXA-23 in intensive care units: Results of a one-day point prevalence in a Tunisian hospital” – Infectious Diseases Now, 2022.
- “Escherichia coli colonizing healthy children in Tunisia: High prevalence of extra-intestinal pathovar and occurrence of non-extended-spectrum-β-lactamase-producing ST131 clone” – International Journal of Antimicrobial Agents, 2018.
- “First report of extensively-drug-resistant Proteus mirabilis isolate carrying plasmid-mediated blaNDM-1 in a Tunisian intensive care unit” – International Journal of Antimicrobial Agents, 2018.
- “NDM-1- and OXA-23-producing Acinetobacter baumannii isolated from intensive care unit patients in Tunisia” – International Journal of Antimicrobial Agents, 2018.
- “Role of association of OmpK35 and OmpK36 alteration and blaESBL and/or blaAmpC genes in conferring carbapenem resistance among non-carbapenemase-producing Klebsiella pneumoniae” – International Journal of Antimicrobial Agents, 2018.
- “An Outbreak of NDM-1-Producing Klebsiella pneumoniae, Associated with OmpK35 and OmpK36 Porin Loss in Tunisia” – Microbial Drug Resistance, 2018.
- “Emergence of plasmid-mediated colistin-resistance in CMY-2-producing Escherichia coli of lineage ST2197 in a Tunisian poultry farm” – International Journal of Food Microbiology, 2018.
- “Rectal Carriage of Extended-Spectrum Beta-Lactamase and Carbapenemase Producing Gram-Negative Bacilli in Intensive Care Units in Tunisia” – Microbial Drug Resistance, 2017.
- “Community fecal carriage of broad-spectrum cephalosporin-resistant Escherichia coli in Tunisian children” – Diagnostic Microbiology and Infectious Disease, 2017.
- “High Prevalence of Gut Microbiota Colonization with Broad-Spectrum Cephalosporin Resistant Enterobacteriaceae in a Tunisian Intensive Care Unit” – Frontiers in Microbiology, 2016.